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Abstract 
Background: Newborn mortality, comprising a third of all under-5 deaths, has hardly changed in low and middle 
income countries (LMICs) including South Africa over the past decade. To attain the MDG 4 target, greater emphasis 
must be placed on wide-scale implementation of proven, cost-effective interventions. This paper reviews economic 
evidence on effective neonatal health interventions in LMICs from 2000–2013; documents lessons for South African 
policy on neonatal health; and identifies gaps and areas for future research.
Methods: A narrative review was performed in leading public health databases for full economic evaluations con-
ducted between 2000 and 2013. Data extraction from the articles included in the review was guided by the Consoli-
dated Health Economic Evaluation Reporting Standards (CHEERS) checklist, and the quality of the included economic 
evaluations was assessed using the Quality of Health Economics Studies Instrument (QHES).
Results: Twenty-seven economic evaluations were identified, from South East Asia and sub-Saharan Africa, with 
those from sub-Saharan Africa primarily focused on HIV/AIDS. Packages of care to prevent neonatal mortality were 
more cost-effective than vertical interventions. A wide variability in methodological approaches challenges the 
comparability of study results between countries. In South Africa, there is limited cost-effectiveness evidence for the 
interventions proposed by the National Perinatal Morbidity and Mortality Committee.
Conclusions: Neonatal strategies have a strong health system focus but this review suggests that strengthening 
community care could be an additional component for averting neonatal deaths. While some evidence exists, having 
a more complete understanding of how to most effectively deploy scarce resources for neonatal health in South 
Africa in the post-2015 era is essential.
Keywords: Economic evaluation, Cost-effectiveness analysis, Literature review, Neonatal health, Low and middle-
income countries
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Background
International child health policy in the last decade has 
been largely shaped by millennium development goal 
4 (MDG 4), to reduce under-5 mortality by two-thirds 
between 1990 and 2015. Accelerated declines have been 
observed in developed regions with under-5 mortality 
reducing by more than 50  % [1]. However, fewer than 
25  % of 137 low and middle income countries (LMICs) 
are on track to reach the MDG 4 target [2]. Persistently 
high neonatal mortality, which now accounts for a greater 
proportion of global child deaths (40 %) than in 1990, is 
one of the contributing factors to this slower than antici-
pated progress [3].
In South Africa, under-5 mortality reduced by 40  % 
from 2006 to 2011 largely due to the successful scale up 
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of prevention of mother to child transmission (PMTCT) 
of HIV [4]. Yet, newborn mortality remains stagnant at 
a level of 14–20 deaths per 1000 live births [3, 5]. This is 
despite the fact that 80 % of births are in facilities [6], and 
there is a national policy of free maternal and child health-
care at public facilities (enacted since 1996) [7]. Health 
care spending is one of the highest in Africa, albeit with 
little return on investment [8]. The high neonatal mortal-
ity rate is associated with poor quality care, sub-optimal 
adherence to guidelines, delays in seeking antenatal care, 
inadequate inter-facility transport for emergency obstet-
ric care and inadequate postnatal care [9].
To accelerate progress beyond 2015 and as South 
Africa moves towards universal health coverage, we need 
to understand which priority interventions can be scaled 
up to save newborn lives, and the related resource impli-
cations. Economic data on essential newborn interven-
tions is limited in South Africa, but several studies have 
been undertaken in other LMICs [10–12].
Policy makers in South Africa are increasingly aware 
of the need to justify health policy decisions on the basis 
of both effectiveness and costs of interventions. Previ-
ous work done by the authors on the cost and impact of 
reducing sodium content in high salt foods [13] led to the 
government’s drafting of policy on salt regulation, setting 
targets for 2016 and 2018 [14]. More recently, work on 
identifying the costs and impact of essential interventions 
for maternal and child health has been adopted by the 
National Department of Health as priority interventions 
for preventing additional deaths of mothers and children 
in the countdown to the Millennium Development Goals 
[15]. Follow-up work focused on family planning, child-
hood diarrhoea and stillbirths, provided insight on the 
impact and costs of scaling up interventions to reduce 
maternal, newborn and child mortality in South Africa 
[16–18]. Despite these efforts, more still needs to be done 
to generate information that is necessary for evidence 
based decision making in South Africa.
This review of economic evaluations of antenatal, intra-
partum and postnatal interventions aims to: (1) identify 
the key interventions for which economic data exist in 
LMICs, (2) assess the relevance of the available data to 
South Africa; (3) identify gaps in knowledge and prior-
ity areas for future research; and (4) to assess the quality 
of the economic evaluations included in the review. This 
information could be useful for South Africa in its pro-
cess of implementing universal health coverage.
Methods
A literature review was conducted by the first and sec-
ond authors between October and December 2013. We 
used the approach by Glanville et al. (2009) to guide the 
literature search [19]. Specific databases which collect 
economic evaluations including the National Health 
Service Economic Evaluation Database (NHS EED), 
Cochrane and the Paediatric Economic Evaluation Data-
base (PEED) were searched first. This was followed by 
top-up searches in large databases namely Medline, 
Embase and the WHO Global Health Library. We elected 
this approach as evidence indicates that commonly used 
search filters for retrieving economic evaluation arti-
cles in large biomedical databases such as Medline and 
Embase suffer from low precision, returning many irrel-
evant records [19]. We used a combination of search 
strategies in each of the databases and these are shown in 
Additional file 1.
Abstracts of each identified article were assessed for 
eligibility using the following inclusion criteria:
  • Articles were published in English in peer-reviewed 
journals (2000–2013);
  • The study setting was LMICs;
  • Full economic evaluations, which compared the costs 
and outcomes of at least 2 alternative strategies;
  • Studies used primary or secondary data;
  • Original articles published in international journals; 
and
  • Published prior to December 2013.
Articles that did not fit this criterion were excluded. 
The period 2008–2013 was chosen for articles focus-
ing on PMTCT because of the rapid advancement and 
changes in PMTCT protocols, and since many of the 
interventions assessed before this period are outdated. 
Assessment for article inclusion was done by the first and 
second authors, with disagreements resolved through 
subsequent discussions. The inter-rater agreement for 
selection was 96 %.
Extraction of information
The Consolidated Health Economic Evaluation Report-
ing Standards (CHEERS)  24 item checklist was used to 
extract information from each of the studies included 
[20]. The CHEERS checklist was designed to be an aid 
to researchers reporting economic evaluations. It sug-
gests standard items that should be included in an eco-
nomic evaluation to facilitate standard reporting. We 
used CHEERS to extract economic information from 
identified articles, including the time horizon, discount 
rate, choice of health outcomes, measure of effective-
ness, incremental costs and outcomes, study perspective 
and comparators. Other information that was extracted 
included the year of publication, authors, affiliation of 
the first author, type of journal and country in which 
the study was undertaken. Data extraction was indepen-
dently done by the first and second authors. Inter-rater 
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agreement for selection was 85  %. Any disagreements 
were resolved through subsequent discussions.
An assessment of quality was made using the 
Quality of Health Economics Studies Instrument 
(QHES), a validated quality-scoring instrument (score 
range =  0–100;  >75 =  high quality) [21]. The QHES is 
a practical quantitative tool for appraising the quality 
of cost-effectiveness studies. Using this tool, studies are 
graded on whether they provide relevant information 
that is standard to reporting in economic evaluations, 
such as the statement of clear objectives, the study per-
spective and its justification, handling of uncertainty 
and choice of the economic model. The checklist gives 
weighting scores to different quality indicators as shown 
in Table  1. The quality scoring was done independently 
by the first and second authors, and then compared for 
agreement. Disagreements were resolved through subse-
quent discussions. The agreement on scoring was 79 %.
Cost-effectiveness was first reported as stated by 
authors and in this paper, cost-effectiveness also includes 
cost-utility and cost-minimization. We standardised costs 
to international dollars using the approach used by Prost 
et  al. (2013), and report all costs and cost-effectiveness 
results in cost per 2013 international dollars (denoted as 
I$) [22]. The reported United States Dollar (US$) were 
converted into local currency using the exchange rates 
for the cost year, adjusted for inflation to calculate the 
cost in the current year of analysis, then reconverted to 
US$ Purchasing Power Parity (PPP) or international dol-
lars. Currency conversion factors on OANDA were used 
in this study [23]. For regional analyses (e.g. sub-Saharan 
Africa), where costs were reported in US$, we adjusted 
for inflation using the regional GDP deflator [24]. We 
assumed that the cost year was the year in which the 
intervention was conducted, if this was not specified in 
the article. Cost-effectiveness thresholds were based on 
WHO recommended methods, i.e., each intervention 
was classified as (a) highly cost-effective if it averted a 
year of life lost or if it averted a DALY for less than the 
national gross domestic product (GDP) per capita (in I$), 
(b) cost effective if 1–3 times GDP per capita, and (c) not 
cost-effective if greater than 3 times the GDP per capita.
Results
A total of 255 articles were identified, of which 28 were 
excluded in the initial screening, because they did not 
meet the basic inclusion criteria (Fig.  1). A further 164 
articles were excluded because they were not economic 
evaluations, or were economic evaluations not done in 
low and middle income countries, or were of children not 
in the neonatal period. A total of 63 articles were selected 
for full text evaluation, of which 37 were excluded 
because they did not meet one or more of the inclusion 
criteria. The remaining 27 articles spanning a 13  year 
period (2000–2013) were included in this review (Addi-
tional file 2: Table S1).
Table 1 The quality of health economic studies (QHES) instrument
Questions Weight
1 Was the study objective presented in a clear, specific, and measurable manner? 7
2 Were the perspective of the analysis (societal, third-party payer, etc.) and reason for its selection stated 4
3 Were variable estimates used in the analysis from the best available source (i.e. randomized control trial—best, expert opinion—worst)? 8
4 If estimates came from a subgroup analysis, were the groups prespecified at the beginning of the study? 1
5 Was uncertainty handled by: (1) statistical analysis to address random events; (2) sensitivity analysis to cover a range of assumptions? 9
6 Was incremental analysis performed between alternatives for resources and costs? 6
7 Was the methodology for data abstraction (including the value of health states and other benefits) stated? 5
8 Did the analytic horizon allow time for all relevant and important outcomes? Were benefits and cost that went beyond 1 year dis-
counted and a justification given for the discount rate?
7
9 Was the measurement of costs appropriate and the methodology for the estimation of quantities and unit costs clearly described? 8
10 Were the primary outcome measure(s) for the economic evaluation clearly stated and were the major short-term, long-term, and nega-
tive outcomes included?
6
11 Were the health outcomes measures/scales valid and reliable? If previously tested, valid and reliable measures were not available, was 
justification given for the measures/scale used?
7
12 Were the economic model (including structure), study methods and analysis, and the components of the numerator and denominator 
displayed in a clear transparent manner?
8
13 Were the choice of economic model, main assumptions and limitations of the study stated and justified? 7
14 Did the author(s) explicitly discuss direction and magnitude of potential biases? 6
15 Were the conclusion/recommendations of the study justified and based on the study results? 8
16 Was there a statement disclosing the source of funding for the study? 3
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Characteristics of included studies
Of the included articles, 5 (19  %) were published before 
2007 and 22 (81 %) between 2007 and 2013 (Table 2). The 
studies were conducted in Africa (59  %), Asia (30  %) or 
included multiple analyses countries from various LMICS. 
The majority of the studies assessed preventive interven-
tions (70 %), while others were of curative (7 %) or diagnos-
tic (7 %) interventions. About 48 % of the studies followed 
a modelling approach, 30  % were based on randomized 
controlled trials and a further 22  % used observational 
studies. More than half (52 %) of the studies reviewed were 
cost-effectiveness analyses (i.e. the outcomes used were 
intermediate measures or natural units, deaths prevented 
or cases detected). The rest (48 %) were cost-utility analy-
ses (i.e. they used composite outcome measures such as 
disability-adjusted life years or quality-adjusted life years). 
Primary data were used in 48 % of the studies.
Quality of included studies
The studies included in the literature review were of vari-
able quality (Table 3). Fourteen (52 %) of the studies were 
graded high, 12 (44 %) were thought to be fair and 1 (4 %) 
was poor.
The proportion of studies that met the criteria for 
reporting of economic evaluations used in the quality 
index tool is given in Table 4. Economic evaluation was 
not the primary objective in all the studies, hence some 
(24  %) did not clearly articulate the objectives of their 
evaluations. The study perspective was stated in 76  % 
of the articles, though some of these did not justify the 
choice of perspectives. The health care provider perspec-
tive was the most common. Sensitivity analyses were 
done in 66 % of the studies. Sensitivity analyses methods 
varied with some studies using one-way [10, 11, 25, 26, 
27], others using probabilistic tests [28–30] and a few 
using both [31]. Incremental analysis was performed in 
66 % of the studies, and 62 % clearly showed the costing 
methods. About 59  % of the papers met the criteria on 
discounting. None of the articles, however, provided a 
justification for the discount rate. The economic model 
used, including the structure, was clearly presented in 9 
(31 %) of the studies and 6 (21 %) justified the choice of 
255 records retrieved from: PubMed, WHO Global 
Health, Cochrane, PEED & NHS EED  
63 articles selected for full text evaluation 
27 studies included in narrative review 
227 articles selected for abstract evaluation 
28 excluded after screening 
titles 
164 arcles excluded based on following criterion:
Not economic evaluaon studies (N=156), not developing 
countries (N=2), Not neonatal period 
(0-28d)/other (N=6)
36 arcles excluded based on following criterion:
Not economic evaluaon studies (N= 7), not developing 
countries (N=1), Not neonatal period/other (N=24), 
Reporng the same intervenon (N=3) 
Fig. 1 Overview of the literature search, inclusion and exclusion criteria
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the economic model. Only 34 % of the studies disclosed 
their funding source.
Summary of the evidence in the included studies
To summarize the evidence, the studies are divided into 
4 groups according to interventions assessed: commu-
nity care packages, facility based neonatal care packages, 
PMTCT programmes and other vertical interventions.
Economic evaluation of community based interventions
There were ten studies that investigated the economic 
impact of community care packages on neonatal morbid-
ity and/or mortality (Table 5). Five were based on cluster 
randomized trials of women’s participatory groups, and 
of these, four were conducted in rural settings in Asia. In 
these studies, women’s group facilitators (who were not 
health workers) received 7–11 days of training and mod-
erated community group meetings. During these meet-
ings, women designed and implemented strategies to 
address obstetric and perinatal problems relevant to their 
setting. In both intervention and control areas, health 
system strengthening activities were conducted, which 
included training of health workers in essential newborn 
care and safe motherhood. In addition, neonatal resus-
citation equipment was donated to all facilities [32]. The 
success of the interventions was attributed to several 
factors including clean delivery practices at home (hand-
washing), immediate postnatal care [11, 33], increased 
uptake of antenatal care (15), increased uptake of institu-
tional deliveries (15), increased care seeking for neonates 
[11] and exclusive breastfeeding for at least 6 weeks [33] 
to 6 months [34] of life.
The main costs included in each trial were the eco-
nomic costs of setting up and running the women’s group 
intervention. Costs related to health service strengthen-
ing were also reported in all studies. However, only one 
study provided input parameters for the cost analysis 
[32]. In this study, personnel costs were the biggest cost-
drivers, accounting for 70  % of total costs. Incremental 
costs per year of life saved differed across settings but 
were lower than the national GDP per capita in all cases. 
Even though life years saved (LYS) was a common out-
come measure, in one trial LYS included both mater-
nal and infant deaths averted [34] whilst the rest only 
included neonatal deaths.
Potential effect modifiers differed from one trial to 
another. In Nepal, women’s groups collaborated with 
female community health workers who had been trained 
in essential newborn care [11]. In Jharkhand, India, pre-
existing women’s groups that were involved in savings 
and credit schemes formed some of the groups that sub-
sequently participated in the trial [33]. In addition, health 
committees were formed that allowed participants to 
express opinions about the management and the design 
of local health services, thereby engaging more closely 
with the public health system. In Malawi, trial member-
ship was expanded to men residing within the study set-
ting [34].
For the remaining five studies, costs and impact of 
variant community care packages were assessed. Two 
of these studies conducted in rural Zambia and Malawi, 
used peer counsellors and traditional births attend-
ants (TBAs) to deliver the interventions [29, 34]. In the 
Lufwanyama Neonatal Survival Study (LUNESP) in Zam-
bia, traditional birth attendants (TBAs) were trained for 
4  days to perform neonatal resuscitation using resus-
citation masks, administer antibiotics and to promptly 
refer neonates with sepsis to health facilities [29]. One 
to two refresher trainings were given every 3–4 months. 
In Muchinji district (Malawi), peer counsellors were 
trained to conduct pregnancy surveillance, health edu-
cation on exclusive breastfeeding, infant care, immuni-
zations, PMTCT and family planning [34]. Incremental 
cost-effectiveness ratios for the TBA and peer-counsellor 
driven interventions were I$74 and I$60 per DALY pre-
vented, respectively, and were much lower than the GDP 
per capita of Zambia and Malawi, respectively. Detailed 
cost analyses were available for one study and indicated 
that personnel costs, arising from the extensive training 
Table 2 Characteristics of studies included in the review
Characteristic N = 27 Percentage
Year of publication
 Before 2007 5 19
 After 2007 22 81
Region
 Africa 16 59
 Asia 8 30
 LMICS 3 11
Intervention type
 Preventive 19 70
 Curative 2 7
 Preventive/curative 4 15
 Diagnostic/screening 2 7
Study design
 Randomized controlled trials 8 30
 Observational 6 22
 Modelling 13 48
Study type
 Cost-utility analysis 13 48
 Cost-effectiveness analysis 14 52
Type of data used
 Primary 13 48
 Secondary 14 52
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accounted for 60 % of total costs [29]. The costs included 
both direct (provider) costs and indirect costs incurred 
due to healthcare seeking.
The other three studies were based on interventions 
implemented in India [32] and Bangladesh [28]. In India, 
a home based package was developed to equip village 
health workers (VHWs) in resuscitation techniques and 
early management of danger signs such as feeding prob-
lems, and breathing difficulties. Furthermore VHWs 
were trained to encourage mothers to practice kanga-
roo mother care, early and exclusive breastfeeding and 
to offer postnatal care [32]. Though detailed information 
was not available, the cost analyses from a provider per-
spective indicated that personnel costs were the biggest 
cost drivers accounting for 70 % of total costs. The inter-
vention was highly cost-effective at I$14/DALY averted 
and this high cost-effectiveness could be partially attrib-
uted to inclusion of still births (not just neonatal deaths) 
in calculation of DALYs averted.
In a similar initiative in Bangladesh, community health 
workers (CHWs) made two home visits to pregnant 
women at 12–16 and 32–34  weeks of gestation, trained 
in birth and neonatal care preparedness and conducted 
three postnatal visits at 1, 3 and 7 days after birth. Fur-
thermore health systems strengthening activities were 
carried out, which included training key staff from local 
health centres in maternal and neonatal health and pro-
vision of essential drugs. Similar to findings from other 
trials, personnel costs accounted for the largest propor-
tion of the recurrent costs (55 %), followed by transpor-
tation. Relative to the control arm, the intervention cost 
was I$211 per additional DALY averted [28]. The cost-
effectiveness ratio was much lower than GDP per capita 
of Bangladesh in 2011, which was I$1700.
Contextual factors potentially impacted on effect and 
cost-effectiveness of interventions. In two trials, train-
ing was conducted by a foreign based neonatologist 
with support from local midwives and facilitators [12, 
29]. Substantial training and retraining was a critical 
component in the trials, with the LUNESP intervention 
[29] offering 2–3 refresher trainings every 2–3  months. 
In all studies, interventions were implemented by Non-
Governmental Organizations (NGOs), with a new work-
force introduced that focused solely on neonatal and/or 
maternal health. Furthermore, in India, the NGO that 
implemented the trial had established a service base 
whilst running a surveillance system in the area prior to 
the study and had earned the trust of the local population 
[32]. Performance-linked remuneration offered to village 
health workers was another important potential effect 
modifier in the trials [32] but details regarding the actual 
unit costs for this were not available.
Facility‑based neonatal care packages
One study investigated the cost-effectiveness of re-
training midwives in essential newborn care (ENC) in 
first level urban health facilities in Zambia [12]. The 
ENC package covered resuscitation techniques, impor-
tance of kangaroo mother care, early and exclusive 
breastfeeding and early detection and management of 
danger signs. This intervention was highly cost-effec-
tive (I$5.71/DALY averted) in comparison to the rest 
of community care packages studied. However, only 
transport costs of the foreign based master trainer were 
included and not salary costs as the trainer worked on a 
voluntary basis.
Economic evaluation of vertical interventions
The vertical intervention studies focused on diverse 
topics ranging from nutritional supplementation [35], 
malaria [36], syphilis [26, 27, 30], neonatal asphyxia, 
bilateral congenital hearing loss [37], hepatitis B [38] and 
Table 3 Quality index scores for  studies included in  the 
review
High = 75–100 %; fair = 50–74 %; poor = 25–49 %
Study Quality index decision 
based on % score
1 Adam et al. (2005) Fair
2 Borghi et al. (2005) High
3 Manasyan et al. (2011) Fair
4 Bang et al. (2005) Fair
5 Tripathy et al. (2004) Fair
6 Lewycka et al. (2013) Fair
7 Fottrell et al. (in Prost et al. 2013) Fair
8 LeFevre et al. (2013) High
9 Owusu-Edusei et al. (2011) High
10 Sicuri et al. (2010) High
11 Sabin et al. (2005) High
12 Sayed et al. (2008) Fair
13 Halperin et al. (2009) Fair
14 John et al. (2008) Fair
15 Robberstad and Ovjen-Olsen (2010) High
16 Orlando et al. (2010) Fair
17 Shah et al. (2011) High
18 Maredza et al. (2013) High
19 Binagwaho et al. (2013) High
20 Hung et al. (2011) High
21 Bomela et al. (2001) Poor
22 Vickerman et al. (2006) Fair
23 Hong et al. (2010) High
24 Hounton et al. (2009) High
25 Huang et al. (2012) High
26 Darmstadt et al. (2007) Fair
27 Fasawe et al. (2013) High
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the role of community health workers in home deliveries 
[32] (Table 2).
Cost-effectiveness ratios were reported as cost per 
deaths averted, DALYs averted, HIV infections pre-
vented, newborn lives saved, case fatality rates and years 
lived with disability. In one study, cost-benefit ratios were 
used [35]. It is difficult to compare cost-effectiveness 
results as the outcomes measured differed across stud-
ies. Even where similar outcomes were measured such as 
DALYs, valuing techniques differed. In some studies the 
YLL (premature mortality) included stillbirths, neonatal 
deaths and miscarriages [26] whilst others only included 
neonatal deaths. Notwithstanding these limitations most 
of the interventions studied were considered cost-effec-
tive in the study settings due to the potentially large num-
ber of life years gained by reducing neonatal deaths.
Amongst the studies that reported cost/DALY, inter-
vention cost-effectiveness ranged from I$2/DALY 
averted for preventive malaria treatment during preg-
nancy to I$326/DALY averted for congenital syphilis 
screening [26]. On average every I$21 saved a neonate 
from asphyxia when a simple bag-and-mask was used for 
resuscitation [32]. Task-shifting of emergency obstetric 
care to general practitioners cost I$200 per decrease in 
neonatal case fatality [10]. Other interventions that were 
considered cost-effective included nutritional interven-
tions to prevent neural tube defects which resulted in a 
benefit to cost ratio of I$46 and prophylactic administra-
tion of lamivudine to mothers to prevent vertical trans-
mission of hepatitis B. The latter had a cost-effectiveness 
ratio less than the willingness-to-pay threshold of Taiwan 
of I$20,000 [39].
A modelled analysis by Darmstadt and colleagues 
(2008) provides comprehensive cost-effectiveness esti-
mates of 16 key neonatal interventions including folic 
acid supplementation, tetanus immunization, syphi-
lis screening and screening for pre-eclampsia [40]. The 
authors show that scaling up these interventions to 90 % 
would save 0.59–1.08 million lives in Asia at an addi-
tional cost of US$1–1.95 billion. In sub-Saharan Africa, 
the same interventions would save 0.45–0.80 million 
newborn lives at a cost of US$0.75–1.47 billion. In addi-
tion, across all the 60 UNICEF countries analysed, one 
neonatal death would be saved by investing an additional 
US$1100–4000. Of note is that packaging interventions 
across various stages (antenatal, intrapartum, postna-
tal) and service delivery modes (family, community) at 
increased coverage would cost an estimated US$0.90–
0.17 billion and avert 13–29 % of deaths in 15 very high 
mortality (NMR > 45) countries.
Economic evaluation of PMTCT interventions
Eight studies on PMTCT interventions were included. Of 
these, one examined the impact of different approaches 
to voluntary counselling and testing (VCT) [41] and the 
rest examined options for postnatal PMTCT (WHO rec-
ommended options A, B, and B+) [31, 42–46]. Option 
A involves giving a woman short-course zidovudine 
(AZT) during pregnancy and nevirapine prophylaxis 
to the infant for the duration of breastfeeding; option B 
Table 4 Proportion of studies that met the selected criteria for grading economic evaluations
Criteria 3 and 4 not included in this table. See Table 1 for full list of criteria
Questions % (N = 27)
1 Was the study objective presented in a clear, specific, and measurable manner? 76
2 Were the perspective of the analysis (societal, third-party payer, etc.) and reason for its selection stated 76
5 Was uncertainty handled by: (1) statistical analysis to address random events; (2) sensitivity analysis to cover a range of assumptions? 66
6 Was incremental analysis performed between alternatives for resources and costs? 65
7 Was the methodology for data abstraction (including the value of health states and other benefits) stated? 76
8 Did the analytic horizon allow time for all relevant and important outcomes? Were benefits and cost that went beyond 1 year dis-
counted and a justification given for the discount rate?
59
9 Was the measurement of costs appropriate and the methodology for the estimation of quantities and unit costs clearly described? 62
10 Were the primary outcome measure(s) for the economic evaluation clearly stated and were the major short-term, long-term, and 
negative outcomes included?
90
11 Were the health outcomes measures/scales valid and reliable? If previously tested, valid and reliable measures were not available,  
was justification given for the measures/scale used?
86
12 Were the economic model (including structure), study methods and analysis, and the components of the numerator and  
denominator displayed in a clear transparent manner?
31
13 Were the choice of economic model, main assumptions and limitations of the study stated and justified? 21
14 Did the author(s) explicitly discuss direction and magnitude of potential biases? 86
15 Were the conclusion/recommendations of the study justified and based on the study results? 93
16 Was there a statement disclosing the source of funding for the study? 34














































































































































































































































































































































































































































































































































































Page 9 of 15Maredza et al. Cost Eff Resour Alloc  (2016) 14:2 
involves giving the HIV-infected pregnant woman life-
long highly active antiretroviral therapy (HAART) during 
pregnancy and for the duration of breastfeeding; option 
B+ continues HAART therapy for life and does not cease 
therapy when the woman stops breastfeeding regard-
less of whether she needs it or not [47]. The studies show 
that PMTCT interventions during pregnancy are gener-
ally cost-effective. However, the cost-effectiveness of the 
available options for postnatal PMTCT (either breast-
feeding with ARV interventions or replacement feeding) 
is dependent on context [44, 46].
In only one modelled study, authors explored the 
impact of preventing unintended pregnancies (through 
family planning) among women living with HIV in high 
prevalent settings including South Africa [48]. They con-
clude that this intervention is highly cost-effective and 
could reduce infant and maternal mortality. The sub-
analysis for South Africa indicates that an additional 
I$284 is needed to avert a DALY with family planning 
programmes [49].
Discussion
This narrative review examines published cost-effective-
ness interventions to improve neonatal health in LMICs 
and identifies knowledge gaps that could potentially 
inform South African policy post-2015. Since 2000, few 
economic evaluations of neonatal interventions have 
been conducted in LMICs. The published literature 
shows that only 27 studies were full economic evalua-
tions. Approximately a third of the studies were commu-
nity based interventions and were conducted in rural 
Asia. Studies conducted in sub-Saharan Africa primarily 
focused on PMTCT with very limited data on cost-effec-
tiveness of broader neonatal care packages.
Generalizing findings to all LMICs is difficult as meth-
odologies to value costs and outcomes are not uniform, 
and differing implementation barriers could have sig-
nificantly influenced the findings. For example in Nepal 
and India, similar community-based packages involving 
women’s groups resulted in much higher cost-effective-
ness in India (compared to Nepal) mainly due to lower 
operating costs [33]. Similarly, the trial of home care in 
Bangladesh [28] and the Indian study [32] had compa-
rable neonatal care packages, but cost-effectiveness was 
15 times higher in India (I$14/DALY averted vs. I$211/
DALY averted). This difference in cost-effectiveness has 
been attributed to the higher density of CHWs per geo-
graphic area, more extensive training and greater num-
ber of postnatal visits. In addition, type and scope of 
costs included differed between the trials. Societal costs 
were not included in India and the provider perspective 
excluded training costs, making it difficult to make a valid 
comparison across studies.
With respect to methodology, 8 of the 10 neonatal 
care package studies used primary data from cluster ran-
domised trials [11, 28, 29, 32–34], whilst many of the 
analyses of vertical interventions used modelling tech-
niques that synthesized data from various sources [27, 
30, 38, 40]. For the latter, input parameters were not 
country specific but based on regional level estimates 
derived from literature. However, inter-country vari-
ations exist and regional level estimates do not always 
apply for countries within the same region. In another 
example, the WHO modelled analysis for sub-Saharan 
Africa estimated that skilled birth attendance is 44  % 
and community interventions that improved safe home 
deliveries were highly cost-effective [25]. However, coun-
tries such as South Africa report skilled birth attendance 
rates of more than 80 % [50] so that cost-effectiveness of 
community based initiatives to improve safe deliveries 
in South Africa might differ from other countries on the 
continent. An additional issue related to the calculation 
of DALYs. In some studies, YLL included stillbirths, mis-
carriages and neonatal deaths [26] whilst others [25, 40] 
only included the latter.
Estimating the impacts of integrating interventions 
required ambitious assumptions as no effectiveness data 
exists for packaged services for neonates in LMICs [40]. 
Some studies did not conduct sensitivity analyses [33], 
making it difficult to assess how cost-effectiveness is 
affected by changes in key input parameters. Although 
we use GDP to set the thresholds, this is quite arbitrary 
and GDP as a measure also has its limitations.
Lastly, the quality of economic evaluation studies, 
which is crucial to understanding generalizability of find-
ings differed. Some studies did not go in depth in describ-
ing the methodology used in the economic evaluation 
[22, 33, 35, 39]. As no standard criteria exist, the type and 
scope of costs differed. Some studies did not give detailed 
cost breakdowns [33, 39, 41], challenging both the com-
parability of findings across studies and validity of extrap-
olating beyond study settings.
What we can conclude from the available evidence
While explicit judgment on the cost-effectiveness evi-
dence is challenging, this review suggests that many 
of the interventions to prevent neonatal mortality and 
morbidity are generally cost-effective. The potentially 
large number of life years gained by preventing neonatal 
deaths is the biggest driver of cost-effectiveness. In terms 
of relative cost-effectiveness, packages of care are more 
cost-effective than vertical interventions, probably due 
to cost-synergies. In terms of costs per life-years gained, 
interventions that improved both neonatal and maternal 
health outcomes were significantly more cost-effective 
[32, 33] than those that targeted neonatal survival only 
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[11, 29]. This finding reinforces the current call to inte-
grate maternal and neonatal health interventions [51].
Though referral level interventions such as emergency 
obstetric care are generally the least cost-effective, there 
is potential for improvement through task shifting to 
lower-level personnel, such as general practitioners and 
nurses. This would improve the viability of this option 
to improve neonatal health outcomes in resource con-
strained settings [10].
What this review adds towards South African strategic 
planning for neonatal health
The review raises several important issues for consid-
eration in South Africa, to improve priority setting for 
maternal, newborn and child health care. Of particular 
note are the health systems strengthening activities iden-
tified which include: prompt provision of essential drugs, 
ensuring resuscitation equipment is available and fully 
functional at health facilities, and providing refresher 
training on neonatal health care to key health workers 
[28, 32]. Whilst facility deliveries and health care utili-
zation are high in South Africa, the facility-based audits 
that are conducted yearly indicate that a variety of health 
system related factors are responsible for 25  % of the 
adverse neonatal health outcomes in district hospitals 
[9]. These factors include sub-standard quality of care, 
inadequate facilities or equipment in neonatal units and 
nurseries, lack of accessible neonatal ICU beds with ven-
tilators, and delays in providing antenatal steroids [9].
The National Perinatal and Neonatal Morbidity and 
Mortality Committee (NaPeMMCo) has identified a sev-
eral interventions highlighted in this review as key to 
improving neonatal survival in South Africa but the com-
mittee lacks supporting economic evaluation evidence 
(Table 6) that could show what investments are required 
to enable this. These interventions include training of 
frontline health workers in providing maternity and neo-
natal care, management of the third stage of labour, HIV 
counselling and testing and initiation and monitoring 
of antiretroviral care. Training and refresher training of 
health workers was identified in this review as a highly 
cost-effective intervention that is critical to strengthening 
clinical governance of maternal, neonatal and child health 
services. In Zambia [12], essential newborn care training 
of health workers in an urban setting is a low-cost inter-
vention that can effectively reduce neonatal mortality. 
The majority of deliveries this study were facility-based, 
as is the case in South Africa. More so, the early neo-
natal death rates of the study setting of 11.6 deaths per 
1000 live births were quite similar to those documented 
in the South African facility audits of 2012–2013 for 7 
out of 9 provinces [9]. Baseline mortality rate is one of 
the key factors that influence overall cost-effectiveness of 
an intervention. High-mortality settings tend to achieve 
the highest cost-effectiveness because resources can be 
potentially used to save many additional lives. In lower 
mortality settings such as the Western Cape Province of 
South Africa (ENNDR = 7 per 1000 live births), the same 
cost-effectiveness level is unlikely to be achieved. Further 
consideration should be given to the fact that the cost-
structures in different study settings might be different, 
and is likely to affect cost-effectiveness.
Birth asphyxia continues to be second or third lead-
ing causes of neonatal mortality in South Africa [9]. This 
review indicates that appropriate monitoring of labour 
by skilled birth attendants and the use of bag and mask 
ventilation are key cost-effective interventions [10, 25, 
29]. In South Africa, the majority of births are attended 
to by skilled health workers. However, inadequate resus-
citation facilities in neonatal units continue to be a chal-
lenge. What the country can learn from this review is 
that preventing deaths from asphyxia does not have to 
be an expensive option. It is worth investing in low-cost 
options such as “bag and mask”, and ensuring that health 
care workers are appropriately trained to use it. Because 
the neonatal mortality rates reported in South Africa are 
much lower than the Indian study [32], one can expect 
lower cost-effectiveness from this intervention. Nonethe-
less the significantly low cost of the bag and mask is likely 
to drive cost-effectiveness even within the South African 
context. A recent model based analysis of interventions 
to improve newborn and child mortality in South Africa 
showed that neonatal resuscitation is likely to save addi-
tional newborn lives and is potentially cost-effective [15, 
17].
South Africa remains at the epicenter of the HIV/AIDS 
epidemic. As such, HIV-related interventions identified 
through this review warrant discussion. One of these 
interventions is providing increased contraception to 
HIV-infected women. According to Halperin et al., pre-
venting unintended births to HIV positive women in 
South Africa can be achieved at an average cost of US$61 
per birth averted. A similar model for increased contra-
ception in the general population of women 15–49 years 
in South Africa showed that the additional costs of scal-
ing up family planning were potentially much lower 
[18]. This underscores the need to consider the different 
assumptions and outcomes, as well as methodologies 
used in conducting such modelling analyses. But the les-
son for South Africa is that contraception targeted at high 
risk groups such as HIV positive women can have a huge 
and positive impact. Analysis of interventions to prevent 
mother to child transmission of HIV indicate that such 
interventions are highly cost-effective. However, inter-
vention cost-effectiveness is highly dependent on contex-
tual factors such as baseline breastfeeding rates, cost of 
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antiretroviral medications and baseline HIV transmission 
rates. The latter reinforces the need to either conduct 
South African specific analyses or to closely examine 
sensitivity analyses of economic evaluation studies per-
formed elsewhere, in order to determine the impact of 
context on cost-effectiveness results.
Neonatal sepsis and infections are another persis-
tent challenge in South Africa that could be addressed 
through cost-effective interventions identified in this 
review namely; presumptive antibiotic therapy for new-
borns, case management of sepsis, meningitis and pneu-
monia, and increased breastfeeding [10, 25, 29]. Evidence 
suggests that these interventions can save lives in South 
Africa, and their costs are potentially low [15, 16, 52]. 
Even under a variety of assumptions, as assessed through 
sensitivity analyses, these interventions remained highly 
cost-effective [25].
While it is tempting to dismiss community care pack-
ages mostly used in other countries that might be better 
suited to settings with low skilled attendance at birth and 
low health care utilization, these interventions could still 
be useful for South Africa, for improving services in the 
various districts and provinces. This is because South 
Africa is a heterogeneous country with potentially vary-
ing needs. In 2012, only 18 out of 52 districts had facil-
ity delivery rates that were equal to or higher than the 
national average of 84 %, and in one district less than 20 % 
of births occurred within a health facility [50]. A recent 
analysis indicates that only 40–50 % of women attended 
antenatal care before 20 weeks in 7 out of 9 provinces and 
in one province it was as low as 30 % [53]. Community 
care packages could address missed opportunities that 
include: identification of HIV-infected women, breast-
feeding promotion and promotion of handwashing with 
soap.
The primary health care re-engineering initiative that 
is aimed at strengthening the primary health care system 
offers an opportunity for delivering community based 
initiatives. Through this process, ward based outreach 
teams (WBOTs) comprising community health workers, 
professional nurses, and environmental health practition-
ers who operate within the community to provide health 
related information on antenatal and postnatal care, 
immunizations and prevention and management of HIV. 
Though the costs of the specific package of services to be 
provided by WBOTs is not known, it should be antici-
pated that these will be higher, since community health 
workers in South Africa demand substantially higher 
remunerations compared to other settings [54].
Consideration should however be given to the source of 
funding and scope of the interventions. Most of the inter-
ventions reviewed in this study were funded and imple-
mented in partnership with local non-governmental 
organizations. In Bangladesh, the success of the interven-
tion was partly attributed to the intense working sched-
ules maintained in the trial. However, such schedules 
might not be realistically feasible in the long term [28]. 
In addition, workers might be remunerated for overtime 
work in practice and since personnel costs are the big-
gest cost drivers [32], cost-effectiveness of interventions 
is likely to be lower than reported in the studies. In addi-
tion, health worker attrition is a significant and costly 
challenge in South Africa [55].
Future research needs for South Africa
Though the review has identified a broad range of inter-
ventions for reducing neonatal morbidity and mortality 
that could be relevant for South Africa, there are spe-
cific interventions, currently being implemented (or pro-
posed) in South Africa that need to be evaluated. These 
include the health systems strengthening initiative which 
is dependent on district clinic specialist teams (DCSTs), 
operating to improve service delivery at PHC level in 
their respective health districts. The DCSTs comprise a 
family physician, obstetrician, paediatrician, anaesthe-
tist, PHC nurse, advanced midwife and paediatric nurse. 
A simple analysis based on salary costs indicates that 
an additional R396 million (US$ 39.6 million) will be 
required every year to fund 172 posts in all 52 districts 
[56]. However, this analysis reflects only salary costs and 
did not include costs of services, training, or supervision. 
Without understanding the full economic costs relative 
to the added benefits, it is difficult to plan for the sus-
tainability of using DCSTs in South Africa. There are no 
comparisons among the interventions evaluated in this 
review, which assess the cost-effectiveness of high-level 
health workers such as DCSTs in improving neonatal 
health.
The studies reviewed did not provide information on 
several issues that could be useful in South Africa, and 
should be considered in future analyses. These include 
maternity waiting homes, interventions that specifi-
cally target women below the age of 18 years and mobile 
technology interventions as an educational medium for 
both pregnant women and health workers. Inadequate 
access to emergency transport is one key modifiable 
factor responsible for the high number of neonatal and 
maternal deaths. Recent evidence from the Free State 
province suggests that improved inter-facility transport 
for pregnant women could save many lives [57], but the 
costs of this intervention or economic costs of scale up 
are unknown.
Limitations
This review assesses published economic evaluations of 
neonatal interventions in peer reviewed journals, and 
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did not include the grey literature such as government 
reports, academic theses and conference proceedings. 
The exclusion of the grey literature could have intro-
duced publication bias, since studies with positive results 
are more likely to be published in peer-reviewed journals 
[58]. We used a validated checklist to assess the quality of 
the economic evaluations. Similar to any quality check-
list the quality of health economics studies instrument is 
prone to the subjective assessment of the reviewer. Thus, 
it cannot be concluded with any level of certainty that the 
quality scores assigned to studies are replicable. Stand-
ardising outcomes such as years of life lost would have 
allowed comparability. However, a number of the studies 
did not give the level of detail required to perform such 
analyses.
Conclusion and recommendations
Since 2000, few economic evaluation studies on neonatal 
health have been conducted in LMICs. The few that exist 
have been conducted mainly in South East Asia. Studies 
conducted in sub-Saharan Africa are largely focused on 
HIV/AIDS. The studies vary in methodology, type and 
scope of costs assessed. Contextual and implementation 
factors influence the relative cost-effectiveness of inter-
ventions. While South African specific policies suggest 
what needs to be done to address neonatal health, and 
evidence of effectiveness exists, economic data are largely 
missing. Successful PMTCT will be an ongoing cost in 
South Africa in the post 2015-era, as donor funding will 
be decreased. Greater understanding is urgently needed 
of the broader resource implications to decrease neonatal 
mortality in South Africa.
To understand the resources required to accelerate pro-
gress towards MDG 4, South Africa needs to develop and 
cost specific packages of care. These could be developed 
by province and district to account for the geographic 
variations in mortality and health care utilization. Avail-
ability of cost-effectiveness information to save newborn 
lives is essential, to ensure sustainable funding alongside 
other health systems goals of equity, acceptability and 
feasibility of implementation.
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